Case Study: Clairity, Inc. achieves up to 5-year breast cancer risk prediction with KUNGFU.AI

Clairity, Inc predicts breast cancer risk up to 5 years ahead with KUNGFU.AI

Clairity, Inc. partnered with KUNGFU.AI to address a significant challenge in healthcare: predicting breast cancer risk using only radiological image data. Their goal was to move beyond traditional methods that rely on patient metadata like age, race, and medical history, which can introduce bias, and instead develop an AI model powered solely by computer vision.

KUNGFU.AI developed and trained a highly accurate AI model on a vast dataset of mammograms. This solution successfully predicts a woman's risk of developing breast cancer up to five years in advance using image data alone. The model received FDA De Novo authorization, a significant milestone that confirms its groundbreaking nature and reliability. This partnership with KUNGFU.AI enabled Clairity to transition their research into a real-world clinical tool, empowering physicians to make earlier, more confident decisions for their patients.

Clairity, Inc